MMP9 and gastric carcinoma: A synthetic small-molecule pan-PI3K inhibitor, LY294002, significantly inhibits the growth of gastric carcinoma while promoting apoptosis, resulting in the downregulation of MMP-2, MMP-9, and VEGF [41].